Portola Pharmaceuticals, Inc. announced the appointment of Ted W. Love, M.D., to its Board of Directors. Dr. Love is a recognized industry leader with more than 25 years of experience in the discovery and development of high impact medicines. Dr. Love currently serves as president and chief executive officer of Global Blood Therapeutics. He previously held executive positions at a number of large biopharmaceutical companies including Onyx Pharmaceuticals, Nuvelo, Inc. and Theravance, Inc. Earlier in his career, Dr. Love held a number of senior management positions at Genentech, where he oversaw the development strategy and execution that led to the approvals of six innovative medicines.